A 26-year-old cisgender woman with HIV presents for follow-up. She tested positive for HIV about 2 months ago but has not yet started antiretroviral therapy. One week ago, she learned that she is pregnant. By her menstrual history, she is at 9 weeks of gestation. Laboratory studies obtained at her initial HIV evaluation visit 5 weeks prior showed a CD4 count of 632 cells/mm3, an HIV RNA level of 41,880 copies/mL, and no significant mutations on an HIV genotypic drug resistance test.
Which one of the following would you recommend for initiating combination antiretroviral therapy for this woman in her first trimester of pregnancy?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 20th, 2023
September 20th, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5